Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oramed Pharmaceuticals (ORMP) Tax Provisions (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Tax Provisions for 2 consecutive years, with $416000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Tax Provisions changed N/A year-over-year to $416000.0, compared with a TTM value of $3.2 million through Dec 2024, changed N/A, and an annual FY2024 reading of $3.2 million, changed N/A over the prior year.
  • Tax Provisions was $416000.0 for Q4 2024 at Oramed Pharmaceuticals, down from $1.1 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.6 million in Q2 2024 and bottomed at $100000.0 in Q3 2022.